V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20078985 | 20087028 | 1.72 | 93 | Palliative (P) | 2017-12-27 | 2018-01-05 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | N | EVEROLIMUS | 100782911 |
| 20079923 | 20087029 | 1.79 | 93 | null | 2018-01-26 | 2018-01-29 | ACELARATE Trial | N | N | VENETOCLAX | 101127750 |
| 20079953 | 20087030 | 1.72 | 52.25 | 03 | 2016-06-20 | 2016-06-20 | MITOMYCIN | 02 | N | NIVOLUMAB | 100988503 |
| 20080096 | 20087031 | 1.78 | 111.7 | Palliative (P) | 2018-02-02 | 2018-02-16 | Avelumab | 02 | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100797431 |
| 20080353 | 20087032 | 1.81 | 75.2 | 03 | 2019-12-16 | 2019-12-23 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | SCOPE2 TRIAL | 100887597 |
| 20081090 | 20087034 | 1.68 | 71.8 | 03 | 2014-08-14 | 2014-08-14 | SCOPE 2 TRIAL | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100837512 |
| 20082020 | 20087035 | 1.73 | 63.5 | Palliative (P) | 2019-05-04 | 2019-05-30 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | CTD | 100971003 |
| 20082467 | 20087037 | 1.82 | 85.9 | 03 | 2016-07-25 | 2016-08-05 | PACLITAXEL | 02 | N | RITUXIMAB | 100330817 |
| 20082507 | 20087038 | null | null | 03 | 2020-02-14 | 2020-02-14 | Hepatoblastoma VHR Block A Cisplatin/Dox | 01 | Y | CISPLATIN + FLUOROURACIL + RT | 100645932 |
| 20082569 | 20087039 | null | 77 | Palliative (P) | 2018-10-14 | 2018-10-14 | Docetaxel 75mg/m2 (21 day) | 01 | N | CYTARABINE | 100547969 |
| 20082574 | 20087040 | 1.55 | 64 | 03 | 2018-03-14 | 2018-04-05 | FLUOROURACIL + RT | 02 | N | GEMCARBO | 101391966 |
| 20082837 | 20087041 | 1.64 | 76.4 | Palliative (P) | 2019-09-26 | 2019-09-26 | Capecitabine + Streptozocin | 02 | N | CAPECITABINE + DOCETAXEL | 100594765 |
| 20083529 | 20087043 | 1.63 | 86.8 | null | null | 2017-05-03 | BORTEZOMIB + THALIDOMIDE | 02 | N | BUSULPHAN | 101510372 |
| 20083770 | 20087044 | 1.76 | 58.65 | 03 | 2019-01-25 | 2019-02-01 | NEO-AEGIS TRIAL | 02 | N | EVEROLIMUS | 101147670 |
| 20083976 | 20087046 | 1.8 | 60.6 | Adjuvant (A) | 2017-07-28 | 2017-08-04 | null | N | N | NEO-AEGIS TRIAL | 100604096 |
| 20084150 | 20087047 | 1.75 | 92.6 | Adjuvant (A) | 2017-03-28 | 2017-03-28 | Fluorouracil + Folinic + RT Bossett | N | N | ESPAC TRIAL | 100861511 |
| 20084600 | 20087049 | 1.6 | null | Palliative (P) | 2020-06-11 | 2020-06-11 | Avelumab | N | N | GEMCARBO | 101845059 |
| 20084647 | 20087050 | 1.46 | 60.6 | Palliative (P) | 2019-07-22 | 2019-07-23 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | NAB-PACLITAXEL | 101566867 |
| 20084700 | 20087051 | 1.73 | null | Palliative (P) | 2017-09-26 | 2017-09-27 | CARBOPLATIN + FLUOROURACIL | 02 | N | INTERFERON ALFA | 101805512 |
| 20084733 | 20087052 | 1.72 | 90.2 | 03 | 2020-05-22 | 2020-06-05 | Carboplatin+Fluorouracil 4 or 5 day | null | N | EOF | 100461725 |
| 20084757 | 20087053 | 1.51 | 50.8 | Palliative (P) | 2018-06-04 | 2018-06-23 | OXALIPLATIN | 02 | N | CVD | 100877133 |
| 20085158 | 20087055 | 1.61 | 74 | Palliative (P) | 2019-11-07 | 2019-11-08 | NIVOLUMAB | 02 | N | EOF | 100071145 |
| 20085579 | 20087057 | null | 68.9 | 03 | null | 2016-03-02 | Panitumumab | Y | null | BORTEZOMIB | 100299022 |
| 20086065 | 20087058 | 1.56 | 77.8 | Palliative (P) | null | 2016-04-13 | BENDAMUSTINE + RITUXIMAB | N | N | ARISTOTLE TRIAL | 101517902 |
| 20086610 | 20087059 | null | null | Palliative (P) | null | 2017-09-30 | OSIMERTINIB | null | N | CHLORAMBUCIL + RITUXIMAB | 100997584 |
| 20086771 | 20087060 | 1.83 | 110.5 | 03 | 2017-04-04 | 2017-04-16 | PACLITAXEL + TRASTUZUMAB | 02 | N | ARISTOTLE TRIAL | 101664916 |
| 20086794 | 20087061 | 1.56 | 70 | Palliative (P) | 2019-06-21 | 2019-06-21 | FCarboSt | 02 | N | BORTEZOMIB | 100342773 |
| 20086997 | 20087062 | 1.75 | 64.3 | null | 2017-05-29 | 2017-05-29 | ST03 TRIAL | 02 | N | AZACITIDINE | 101736938 |
| 20088412 | 20087063 | null | 80.9 | Adjuvant (A) | 2019-04-12 | 2019-04-17 | CHOP R - 21 days | N | N | CISPLATIN + FU + TRASTUZUMAB | 101157438 |
| 20088637 | 20087064 | 1.83 | 82 | Palliative (P) | 2019-07-05 | 2019-07-05 | CHOP R - 21 days | 02 | N | PANITUMUMAB | 100286342 |
| 20088980 | 20087065 | 1.78 | 112.9 | Palliative (P) | 2019-02-20 | 2019-02-21 | Cisplatin + Vinorelbine (IV) | 02 | Y | RALTITREXED | 101409264 |
| 20089065 | 20087066 | 1.61 | 69.8 | 03 | 2020-05-31 | 2020-06-13 | HEP SIOPEL 6 Cisplatin | null | N | PHITT B OR C CISPLATIN | 100784652 |
| 20089263 | 20087067 | 1.55 | 113.35 | null | null | 2017-03-15 | CISPLATIN + FLUOROURACIL + RT | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 100314494 |
| 20089849 | 20087068 | 1.72 | 75 | Palliative (P) | 2019-11-16 | 2019-11-30 | Irinotecan 14day | 02 | N | DOXORUBICIN | 100096790 |
| 20090230 | 20087069 | 1.74 | 94.7 | Palliative (P) | 2019-01-09 | 2019-01-12 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100597289 |
| 20090331 | 20087070 | 1.53 | 75 | 03 | 2018-02-21 | 2018-03-08 | CEMIPLIMAB | 02 | N | RITUXIMAB | 101204687 |
| 20090998 | 20087071 | 1.71 | 65.4 | Palliative (P) | 2016-08-27 | 2016-08-28 | MITOMYCIN | 01 | N | PACLITAXEL | 101006548 |
| 20091353 | 20087072 | 1.74 | 77.4 | Adjuvant (A) | 2021-06-24 | 2021-06-24 | Hydroxycarbamide | N | N | CISPLATIN + DOXORUBICIN + FLUOROURACIL + VINCRISTINE | 101772499 |
| 20091795 | 20087074 | 1.69 | null | 03 | 2016-09-04 | 2016-09-16 | EOF | 02 | N | RALTITREXED | 101108110 |
| 20091883 | 20087075 | 1.6 | 69 | 03 | 2019-12-17 | 2019-12-18 | Bortezomib + MELPHALAN | 02 | N | GO2 TRIAL | 101495733 |
| 20092119 | 20087077 | 1.75 | 82.3 | 03 | 2021-08-05 | 2021-09-01 | CAP + RT | 02 | N | MELPHALAN + THALIDOMIDE | 101310999 |
| 20092221 | 20087079 | null | null | 03 | 2016-11-11 | 2016-11-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | ESPAC TRIAL | 101333061 |
| 20092250 | 20087080 | null | 94.9 | Palliative (P) | 2019-08-29 | 2019-09-05 | Sunitinib | 02 | N | CARBO + FLUOROURACIL | 101555793 |
| 20092372 | 20087081 | null | null | null | 2019-06-30 | 2019-07-03 | NAB PACLITAXEL | 02 | N | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 101615191 |
| 20092375 | 20087082 | 1.78 | 81.2 | 03 | 2017-07-25 | 2017-08-14 | Carboplatin + Pemetrexed | 02 | N | PHITT | 101024247 |
| 20092471 | 20087083 | 1.57 | 60.6 | null | 2018-08-29 | 2018-09-25 | FOXTROT TRIAL | 02 | N | CISPLATIN + IFOSFAMIDE + MITOMYCIN | 100716384 |
| 20092503 | 20087084 | 1.59 | 79.4 | 03 | 2019-11-22 | 2019-11-22 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | Y | MELPHALAN | 100935741 |
| 20092505 | 20087085 | 1.64 | 67 | null | 2015-11-23 | 2015-12-22 | CARBOPLATIN + VINORELBINE | null | N | CISPLATIN + PEMETREXED | 100962493 |
| 20092564 | 20087086 | 1.6 | 58.8 | 03 | 2018-06-27 | 2018-07-09 | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 02 | N | CAP + RT | 100064765 |
| 20092602 | 20087087 | 1.77 | 71.4 | null | 2014-12-29 | 2014-12-29 | Cape +Cetuximab +Oxalip (3 wk) Load | 02 | N | OXALIPLATIN | 100565040 |